STAAR Surgical Co Payments to Acquire Debt Securities, Available-for-sale
STAAR Surgical Co (STAA) reported Payments to Acquire Debt Securities, Available-for-sale of $32.75 million for the 6-month period ending 2026-07-03, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2026-08-12
- STAAR Surgical Co payments to acquire debt securities, available-for-sale for the quarter ending 2026-07-03 was $28.23M.
- STAAR Surgical Co payments to acquire debt securities, available-for-sale for the quarter ending 2026-04-03 was $4.52M, a 69.24% decline year-over-year.
- STAAR Surgical Co payments to acquire debt securities, available-for-sale for the quarter ending 2026-01-02 was $48.90M, a 156.74% increase year-over-year.
- STAAR Surgical Co payments to acquire debt securities, available-for-sale for the quarter ending 2025-09-26 was $11.77M, a 71.25% decline year-over-year.
- STAAR Surgical Co payments to acquire debt securities, available-for-sale for fiscal 2026 was $75.36M, a 6.08% decline from fiscal 2024.
- STAAR Surgical Co payments to acquire debt securities, available-for-sale for fiscal 2024 was $80.24M, a 53.38% increase from fiscal 2023.
- STAAR Surgical Co payments to acquire debt securities, available-for-sale for fiscal 2023 was $52.31M, a 66.41% decline from fiscal 2022.
- STAAR Surgical Co payments to acquire debt securities, available-for-sale for fiscal 2022 was $155.75M.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2026-07-03 | $28.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $32.75M 10-Q · filed 2026-08-12 | $81.65M derived: sum of 3 quarters · filed 2026-08-12 | $93.42M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-04-03 | $4.52M 10-Q · filed 2026-05-13 | $53.42M derived: sum of 2 quarters · filed 2026-05-13 | $65.19M derived: sum of 3 quarters · filed 2026-05-13 | $65.19M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-01-02 | $48.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $60.67M derived: sum of 2 quarters · filed 2026-03-03 | $60.67M derived: sum of 3 quarters · filed 2026-08-12 | $75.36M 10-K · filed 2026-03-03 |
| 2025-09-26 | $11.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $11.77M derived: sum of 2 quarters · filed 2026-08-12 | $26.46M 10-Q · filed 2025-11-05 | $45.51M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-27 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $14.69M 10-Q · filed 2026-08-12 | $33.74M derived: sum of 3 quarters · filed 2026-08-12 | $74.68M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-28 | $14.69M 10-Q · filed 2026-05-13 | $33.74M derived: sum of 2 quarters · filed 2026-05-13 | $74.68M derived: sum of 3 quarters · filed 2026-05-13 | |
| 2024-12-27 | $19.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $59.99M derived: sum of 2 quarters · filed 2026-03-03 | $80.24M 10-K · filed 2026-03-03 | |
| 2024-09-27 | $40.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $61.19M 10-Q · filed 2025-11-05 | ||
| 2024-06-28 | $20.25M 10-Q · filed 2025-08-06 | |||
| 2023-12-29 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $9.71M derived: sum of 2 quarters · filed 2026-03-03 | $24.87M derived: sum of 3 quarters · filed 2026-03-03 | $52.31M 10-K · filed 2026-03-03 |
| 2023-09-29 | $9.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $24.87M derived: sum of 2 quarters · filed 2024-10-30 | $52.31M 10-Q · filed 2024-10-30 | $112.49M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-06-30 | $15.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $42.60M 10-Q · filed 2024-08-07 | $102.77M derived: sum of 3 quarters · filed 2025-02-21 | |
| 2023-03-31 | $27.45M 10-Q · filed 2024-05-07 | $87.62M derived: sum of 2 quarters · filed 2025-02-21 | ||
| 2022-12-30 | $60.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $155.75M 10-K · filed 2025-02-21 | ||
| 2022-09-30 | $95.58M 10-Q · filed 2023-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |